Rare diseases
Investigational molecules
Locations
A study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene
GermanyA Study of Olpasiran for Patients With Stable Heart and Blood Vessel Disease and High Lipoprotein(a) to Measure Changes in Artery Plaque Using Heart Scans
GermanyStudy of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia
GermanyA study testing visugromab, nivolumab, and lenvatinib for patients with advanced liver cancer that cannot be removed by surgery after previous treatment failed
GermanyStudy of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy
GermanyA Study of Brivekimig Compared to Placebo in Patients with Moderate to Severe Hidradenitis Suppurativa
GermanyA study testing zanidatamab combined with chemotherapy before surgery in patients with HER2-positive breast cancer
GermanyA study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis
GermanyA study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression
GermanyTesting zongertinib compared to standard treatment in patients with early-stage non-small cell lung cancer with HER2 mutations after surgery
GermanyA study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before
GermanyA Study of Amivantamab With Carboplatin and Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
